
TRYNGOLZA® Wins FDA Approval as First sHTG Treatment to Lower Triglycerides and Pancreatitis Risk
TRYNGOLZA® becomes the first and only FDA-approved treatment for severe hypertriglyceridemia, reducing both triglyceride levels and the risk of acute pancreatitis. Ionis Pharmaceuticals has secured a major regulatory milestone with…












